Comparative Studies of Biosimilar Medicinal Products
نویسندگان
چکیده
منابع مشابه
The scope and requirements related to preclinical and clinical studies of a new medicinal product, including biotechnological and biosimilar products.
The article presents an outline of the requirements concerning the planning of preclinical and clinical studies, necessary for the legal approval of a medicinal product. It describes the clinical research plan of innovative and generic pharmaceutical products, taking into account the specific situations in which the assessment of biological equivalence of a generic product is not possible based...
متن کاملcomparative dna interaction studies of antiviral drug, zidovudine and its complex using different instrumental methods
هدف از این مطالعه بررسی امکان استفاده از داروهای شناخته شده در درمان سایر بیماریها به عنوان داروهای ضد سرطان است. همچنین با استفاده از این داروها در ساختمان کمپلکس فلز می توان شاخص های دارویی بدست آمده را بررسی نمود. داروی ضد ویروس ایدز(hiv)به نام زیدوودین(azt)انتخاب و.کمپلکس.محلول.در.آب[pt(azt)2]cl2سنتزو به روشهای مختلف فیزیکی و شیمیایی شناسایی گردید. بر هم کنش مقایسه ای این دارو و کمپلکس پلا...
15 صفحه اولComparative studies of three types of products (remanufacturing, refurbished and new products) on warranty cost and profitability
Employing remanufactured and refurbished products are among the new strategies that companies used to raise their profits as well as protects environment. Although used product equipment gives an opportunity to purchase latest technology, customers are doubtful about quality and reliability of these products. Because of limitation that developing countries faces in buying new products, some cou...
متن کاملBiosimilar medical products - licensing, pharmacovigilance and interchangeability.
The use of biological medicine has significantly increased in recent decades and has made substantial contributions to improving the effectiveness of therapies in many diseases. The expiration of patents of biological innovative medicines enables copies of those drugs called similar biological products (biosimilars) to be approved by regulatory authorities and to enter in clinical use. Biosimil...
متن کاملBiosimilar Products Scientific Principles , Challenges , and Opportunities
T he Chemistry, Manufacturing, and Controls (CMC) Strategy Forum held on 22 January 2012 in San Francisco, CA, focused on selected scientific and regulatory aspects in the development of biosimilar products. Such products are becoming an increasingly important area of interest for both the biopharmaceutical industry and regulatory agencies. Biosimilars are highly complex, and scientists have be...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products
سال: 2019
ISSN: 2619-1172,1991-2919
DOI: 10.30895/1991-2919-2019-9-2-93-100